CRN’s Peptide Synthesis Core recently installed the CEM Multipep 2 Parallel Peptide Synthesizer, allowing the facility to offer three new high-throughput service lines: peptide library synthesis, peptide array synthesis, and parallel small-scale peptide synthesis.

With support from John Potocsnak and his family, CRN director Samuel Stupp has made significant progress over the last four years in advancing an innovative therapy for spinal cord injury.

A CRN research team led by Ayush Batra and Samuel Stupp published a study describing an injectable therapy that protects the brain after ischemic stroke, the most common type of stroke. In a mouse model, the therapy successfully crossed the blood-brain barrier and significantly reduced brain damage.